Home
>
National Drug Code (NDC)
>
Ondansetron
Ondansetron - 17856-0691-5 - (Ondansetron)
Drug Information of Ondansetron
| Product NDC: | 17856-0691 |
| Proprietary Name: | Ondansetron |
| Non Proprietary Name: | Ondansetron |
| Active Ingredient(s): | 4 mg/5mL & nbsp; Ondansetron |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ondansetron
| Product NDC: | 17856-0691 |
| Labeler Name: | Atlantic Biologicals Corps |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091483 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101217 |
Package Information of Ondansetron
| Package NDC: | 17856-0691-5 |
| Package Description: | 5 mL in 1 CUP (17856-0691-5) |
NDC Information of Ondansetron
| NDC Code | 17856-0691-5 |
| Proprietary Name | Ondansetron |
| Package Description | 5 mL in 1 CUP (17856-0691-5) |
| Product NDC | 17856-0691 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ondansetron |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20101217 |
| Marketing Category Name | ANDA |
| Labeler Name | Atlantic Biologicals Corps |
| Substance Name | ONDANSETRON HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
